Nu Skin Enterprises (NYSE:NUS – Get Free Report) will announce its earnings results after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of $0.20 per share for the quarter. Nu Skin Enterprises has set its FY24 guidance at $0.75-0.95 EPS and its Q3 guidance at $0.08-0.18 EPS.Parties that wish to register for the company’s conference call can do so using this link.
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last posted its earnings results on Thursday, August 8th. The company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.04. Nu Skin Enterprises had a negative net margin of 8.05% and a positive return on equity of 7.80%. The firm had revenue of $439.10 million for the quarter, compared to analyst estimates of $431.87 million. During the same period in the previous year, the firm posted $0.54 EPS. The company’s revenue for the quarter was down 12.2% compared to the same quarter last year. On average, analysts expect Nu Skin Enterprises to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Nu Skin Enterprises Stock Performance
NUS opened at $6.34 on Tuesday. Nu Skin Enterprises has a fifty-two week low of $5.95 and a fifty-two week high of $20.75. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 1.33. The firm has a market capitalization of $315.11 million, a price-to-earnings ratio of -2.13 and a beta of 1.14. The company’s 50 day moving average price is $7.06 and its two-hundred day moving average price is $10.03.
Nu Skin Enterprises Dividend Announcement
Wall Street Analyst Weigh In
NUS has been the topic of a number of research reports. DA Davidson reduced their target price on shares of Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating on the stock in a report on Monday, August 12th. Citigroup reduced their price objective on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research note on Tuesday, October 22nd. Finally, StockNews.com lowered shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Wednesday, October 23rd.
View Our Latest Stock Report on NUS
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Further Reading
- Five stocks we like better than Nu Skin Enterprises
- How to buy stock: A step-by-step guide for beginners
- Intel: Is Now the Time to Be Brave?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.